| 2024-06-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CMO & EVP Dev & Med Affairs | 2,103 0.0016% | $230.99 | $485,773 | +6.14% | |
| 2024-02-28 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CMO & EVP Dev & Med Affairs | 574 0.0005% | $155.30 | $89,145 | -3.37% | |
| 2024-02-16 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CMO & EVP Dev & Med Affairs | 1,308 0.001% | $148.06 | $193,666 | +2.09% | |
| 2023-08-07 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CMO & EVP Dev & Med Affairs | 4,166 0.0033% | $183.89 | $766,083 | -10.49% | |
| 2023-08-04 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CMO & EVP Dev & Med Affairs | 3,461 0.0028% | $185.85 | $643,223 | -11.05% | |
| 2023-04-28 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CMO & EVP Dev & Med Affairs | 2,455 0.002% | $199.02 | $488,595 | -9.55% | |
| 2023-04-27 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CMO & EVP Dev & Med Affairs | 1,839 0.0015% | $194.59 | $357,855 | -8.05% | |
| 2023-03-03 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CMO & EVP Dev & Med Affairs | 18,072 0.0144% | $200.00 | $3.61M | -7.07% |